+11.8%
GSK vs DOCU
+11.4%
+0.4%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DOCU | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.4% | -2.0% | +0.5% | -1.5% |
| 7D | +3.6% | -3.2% | +6.8% | +3.5% |
| 30D | +8.2% | +15.7% | -7.5% | +8.8% |
| 3M | -1.2% | +37.3% | -38.4% | +0.4% |
| 6M | +1.9% | +63.1% | -61.2% | +5.3% |
| YTD | +5.5% | +15.4% | -9.9% | +9.8% |
| 1Y | +11.8% | +11.3% | +0.5% | +17.0% |
| All | +11.8% | +11.4% | +0.4% | +17.0% |
Cumulative growth
Daily Returns
Daily percentage return beside DOCU.
Daily Out/Under-Performance
Portfolio return minus DOCU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DOCU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DOCU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling